Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York

por Fierro, Luca, Nesheiwat, Nora, Naik, Hetanshi, Mistry, Pramod K., Balwani, Manisha
Publicado 2021

Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York

por Fierro, Luca, Nesheiwat, Nora, Naik, Hetanshi, Narayanan, Praveena, Mistry, Pramod K., Balwani, Manisha
Publicado 2021

The N370S/R496H genotype in type 1 Gaucher disease – Natural history and implications for pre symptomatic diagnosis and counseling

por Zeid, Natasha, Stauffer, Chanan, Yang, Amy, Naik, Hetanshi, Fierro, Luca, Ganesh, Jaya, Balwani, Manisha
Publicado 2020

The role of glucosylsphingosine as an early indicator of disease progression in early symptomatic type 1 Gaucher disease

por Stiles, Ashlee R., Huggins, Erin, Fierro, Luca, Jung, Seung-Hye, Balwani, Manisha, Kishnani, Priya S.
Publicado 2021

eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials

por Manjrekar, Kriti, Freeman, Mary, Hedstrom, Karli, Fierro, Luca, Naik, Hetanshi, Diaz, George, Balwani, Manisha, Ganesh, Jaya
Publicado 2022